Comparing Wegovy vs Mounjaro: Mechanisms and Dosing
What Is the Core Difference Between Wegovy and Mounjaro Mechanisms?
The fundamental difference between Wegovy and Mounjaro lies in their active ingredients and how they work in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics one natural fullness hormone. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously, creating a dual-action approach to appetite regulation. This means Mounjaro works on two hormone pathways whilst Wegovy focuses on one highly effective pathway. Both are prescription-only medicines that require clinical assessment and ongoing prescriber support.
Understanding what is the difference between Wegovy and Mounjaro also involves their approval timelines and clinical development. Wegovy received MHRA approval first and has extensive real-world usage data across the UK. Mounjaro represents newer dual-receptor technology with its own clinical trial programme. Both treatments must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber can explain which mechanism may be more suitable based on your individual medical history and weight management goals.
Wegovy vs Mounjaro Pricing and Value Comparison
EverydayMeds offers transparent pricing for both treatments, allowing you to compare costs across equivalent treatment stages. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Mounjaro follows its own dosing schedule with different milligram strengths, starting from comparable entry-level pricing. Both treatments include convenient bundle options like our Intro Duo (£169.99) and Progress Trio (£369.99) packages. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for additional savings.
When considering what is the difference between Wegovy and Mounjaro costs, factor in the complete treatment journey rather than just initial prices. Both require dose escalation over several months to reach maintenance levels, and both involve ongoing monthly costs for sustained weight management. EverydayMeds' bundle pricing provides convenience through Reliable Supply and fewer separate orders. Our clinical team can discuss expected treatment duration and budget planning during your assessment, ensuring you understand the full investment required for either option.
Clinical Evidence for Wegovy vs Mounjaro Weight Management
Wegovy's efficacy comes from the landmark STEP clinical trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The STEP programme also demonstrated sustained weight management at two years and cardiovascular benefits in the SELECT trial. These results established semaglutide as a significant advancement in prescription weight management.
Mounjaro's clinical evidence stems from its own comprehensive trial programme, demonstrating the potential benefits of dual GIP and GLP-1 receptor activation. When comparing what is the difference between Wegovy and Mounjaro effectiveness, it's important to note that direct head-to-head studies between the two treatments are limited. Both have shown meaningful weight loss results in their respective clinical programmes, though different trial designs make direct percentage comparisons inappropriate.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy's semaglutide works by mimicking GLP-1, a hormone naturally released by your intestines after eating. This hormone signals to your brain that you're full, reducing appetite and helping you feel satisfied with smaller portions. Semaglutide also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. The medication targets specific brain regions involved in appetite regulation, potentially reducing food cravings and the desire to eat. As a once-weekly injection, Wegovy maintains consistent hormone-like activity throughout the week, providing steady appetite suppression support.
Ordering Both Wegovy and Mounjaro Through EverydayMeds
EverydayMeds streamlines access to both treatments through our comprehensive service model. Your journey begins with a 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (express 24-hour service available), determining suitability for either Wegovy or Mounjaro based on clinical criteria. Once approved, your medication ships via next-day cold-chain delivery, maintaining proper temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK safety standards and regulatory requirements.
Storage and Practical Differences Between Wegovy vs Mounjaro
A key practical difference between Wegovy and Mounjaro involves storage requirements and travel convenience. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability once removed from the fridge. Wegovy pens can remain at room temperature below 30°C for up to 6 weeks, whilst Mounjaro pens are limited to 21 days at room temperature. This gives Wegovy a significant advantage for travel, work schedules, or situations where refrigeration access is limited. Both use pre-filled pen injectors, though Wegovy uses Novo Nordisk's FlexTouch technology whilst Mounjaro employs its own pen design.
Choosing Between Dual-Action vs Single-Action Weight Management
The choice between Wegovy's single GLP-1 action and Mounjaro's dual GIP-GLP-1 approach represents different philosophies in weight management medicine. Wegovy's focused GLP-1 targeting has extensive real-world data and established efficacy patterns. Mounjaro's dual-receptor approach theoretically offers broader metabolic effects but represents newer technology with evolving understanding. Neither approach is inherently superior - the optimal choice depends on individual patient factors, medical history, and response patterns.
Understanding what is the difference between Wegovy and Mounjaro extends beyond mechanism to include practical considerations like injection experience, side effect profiles, and personal treatment preferences. Some patients may respond better to single-pathway targeting, whilst others might benefit from dual-pathway activation. Your prescriber will consider factors like previous medication responses, concurrent health conditions, and treatment goals when recommending between these approaches.
Start Your Wegovy or Mounjaro Journey Today
Both Wegovy and Mounjaro represent significant advances in prescription weight management, each offering unique benefits for different patient needs. EverydayMeds' comprehensive service removes barriers to accessing either treatment through streamlined clinical assessment and rapid prescription fulfillment. New customers can use code FIRST40 at checkout, whilst returning customers apply DOSE25 for ongoing savings. Our clinical team supports you throughout your treatment journey, monitoring progress and adjusting approaches as needed. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which treatment aligns with your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
